| Business quality | Scotts Miracle-Gro is the leading marketer of branded consumer lawn and garden products in North America, selling lawn fertilizer, grass seed, garden soil, plant food, weed control, and pest control under iconic brands including Scotts, Miracle-Gro, Ortho, and Tomcat. US Consumer net sales reached $2.74 billion in the first nine months of FY2026, up 2%, and branded product sales rose 4.5% year to date. | High |
| Moat | Moat comes from brand recognition built over more than 150 years, dominant shelf placement at Home Depot, Lowe, Walmart, club, and hardware retailers, deep distribution relationships, and consumer habit. E-commerce now represents 13% of POS dollars, up 300 basis points, extending the reach of the branded portfolio. | Medium-high |
| Management | Nate Baxter was appointed president and CEO on June 29, 2026, succeeding Jim Hagedorn, who led the company for about 40 years. Baxter joined in 2023 and served as president and COO before the transition. The Hagedorn Partnership, the largest shareholder, publicly supports the new CEO. Pete Shumlin was elected Chairman. Management quality is unproven under the new team, though the transition has been described as smooth. | Medium |
| Financial trend | Financial trends are improving. First nine months net sales rose 2% to $2.99 billion, gross margin expanded 130 basis points to 35.8% on a non-GAAP basis, adjusted EBITDA rose 5% to $686.6 million, and the company raised its FY2026 adjusted EPS guidance to $4.30-$4.45. Net leverage improved to 3.78x from 4.15x. Book equity remains negative at about -$209 million. | Medium-high |
| Valuation | At $67.12, SMG trades at about 14.4x forward earnings, 10.1x trailing free cash flow, 1.1x sales, and a 3.91% dividend yield. The trailing PE near 54x is inflated by one-time impairment, restructuring, and severance charges. The forward multiple is reasonable for the improving earnings path, with a consensus price target of $77.17. | Medium-high |
| Technical trend | SMG rallied from about $52 in late 2025 to a 52-week high of $75.34 in July 2026, then pulled back to the mid-$60s. Price holds above the 50-day moving average near $64.67 and the 200-day moving average near $61.84. RSI is near 49, neutral, and beta is a high 1.83. | Medium |
| Risk level | Elevated, though improving. Total debt is about $2.1 billion versus $27.7 million of cash, book equity is negative, demand is weather-dependent and seasonal, commodity and freight costs from the Iran conflict create margin risk, and a brand new CEO team is unproven. Short interest is 8.96% of shares outstanding. | Medium-high |
| AI confidence | High for descriptive facts and audited calculations, medium for forward scenarios and chart levels. | High data confidence |
| Investment certainty | Medium-low. The page frames scenarios and monitoring rules, not a buy or sell instruction. | Medium-low |